Increased levels of HGF in plasma has been shown to correlate with poorer overall survival, and patients with stage I lung cancer with high levels of expressed HGF have a poorer prognosis than patients with stage II–III lung cancer with low expression of HGF [31]. Here, HGF is linked to lung cancer.